We are a highly experienced digital first company focused exclusively on cell and gene therapy process development and manufacturing.
We are the partner of choice in high quality GxP development and manufacturing in Advanced Therapy Medicinal Products.
We take your cell therapy ideas and make them into workable medical interventions for patients, all in a regulatory compliant and quality managed system, to get it right first time. Based on brilliant ideas and curious capable minds, we partner with biotechs and academic centres to bring novel ATMP therapies to market and thus to patients who urgently need them. We have highly personalised approaches from the patient to the client to the treatment outcome.
Company Details
- Employees
- 11
- Founded
- -
- Address
- Lyndon House, 62 Hagley Road,, Birmingham,england B16 8pe,united Kingdom
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://adthera.bio
- Keywords
- ATMP, CDMO, C>, process development, cell and gene manufacturing, process innovation, digitalfirst, continuous improvement, advanced therapies, regenerative medicine, digitization, automation, cell therapy, CMO, clinical manufacturing, CGT.
- HQ
- Birmingham, England
Adthera Bio Questions
Adthera Bio's website is https://adthera.bio
Adthera Bio's LinkedIn profile is https://uk.linkedin.com/company/adthera-bio
Adthera Bio has
11 employees.
View email and phone details for 11
employees at Adthera Bio.
Adthera Bio's industry is
Biotechnology Research
Adthera Bio's top competitors are
Quell Therapeutics,
Swarm Oncology,
Achilles Therapeutics Plc,
Cellular Origins,
Cell And Gene Therapy Catapult,
Autolomous,
Resolution Therapeutics,
Ori Biotech,
Roslinct,
Delin Ventures.
Adthera Bio's categories are Biotechnology Research
Adthera Bio's founding year is 2022
